RIAS
MCRB icon

Rachor Investment Advisory Services’s Seres Therapeutics MCRB Stock Holding History

Rachor Investment Advisory Services’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.7K Hold
1,477
– – 0.01% 98
2026
Q1 		$13.1K Hold
1,477
– – 0.01% 104
2025
Q4 		$22K Buy
+1,477
New +$25.8K 0.01% 79

Other funds holding MCRB

Vontobel Holding
Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
CA
Continuum Advisory Eagle, Idaho $1.24B AUM 30.12% 1-Year Est. Return
WTC
WhitTier Trust Company Reno, Nevada $5.35B AUM 29.91% 1-Year Est. Return

Rachor Investment Advisory Services's MCRB Position: Q2 2026 in Review

Rachor Investment Advisory Services held its Seres Therapeutics (MCRB) position steady in Q2 2026 at 1,477 shares worth $11.7K. The position accounts for 0.01% of the portfolio, ranked #98.

Rachor Investment Advisory Services first reported a position in MCRB in Q4 2025 and has held it in 3 quarters since. The position peaked at $22K in Q4 2025. 5 funds tracked by Wall St. Rank hold MCRB as of Q2 2026.

  • Rachor Investment Advisory Services held 1,477 shares of Seres Therapeutics worth $11.7K as of Q2 2026.
  • Rachor Investment Advisory Services left its Seres Therapeutics share count unchanged in Q2 2026.
  • Seres Therapeutics made up 0.01% of Rachor Investment Advisory Services's portfolio in Q2 2026, its #98 holding.
  • Rachor Investment Advisory Services first reported a position in Seres Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Rachor Investment Advisory Services's Seres Therapeutics position peaked at $22K in Q4 2025.
  • 5 funds tracked by Wall St. Rank held Seres Therapeutics as of Q2 2026.

Based on Rachor Investment Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.